Page 55 - Read Online

Page 12 of 13 Gambari et al. J Cancer Metastasis Treat 2019;5:55 I http://dx.doi.org/10.20517/2394-4722.2019.18

79. Geraldo LHM, Garcia C, da Fonseca ACC, Dubois LGF, de Sampaio E, et al. Glioblastoma therapy in the age of molecular medicine.
Trends Cancer 2019;5:46-65.
80. Anjum K, Shagufta BI, Abbas SQ, Patel S, Khan I, et al. Current status and future therapeutic perspectives of glioblastoma multiforme
(GBM) therapy: A review. Biomed Pharmacother 2017;92:681-9.
81. Lozada-Delgado EL, Grafals-Ruiz N, Vivas-Mejía PE. RNA interference for glioblastoma therapy: Innovation ladder from the bench to
clinical trials. Life Sci 2017;188:26-36.
82. Touat M, Idbaih A, Sanson M, Ligon KL. Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann
Oncol 2017; 28:1457-72.
83. Hermansen SK, Kristensen BW. MicroRNA biomarkers in glioblastoma. J Neurooncol 2013;114:13-23.
84. Khalil S, Fabbri E, Santangelo A, Bezzerri V, Cantù C, et al. miRNA array screening reveals cooperative MGMT-regulation between
miR-181d-5p and miR-409-3p in glioblastoma. Oncotarget 2016;7:28195-206.
85. Chan XH, Nama S, Gopal F, Rizk P, Ramasamy S, et al. Targeting glioma stem cells by functional inhibition of a prosurvival
oncomiR-138 in malignant gliomas. Cell Rep 2012;2:591-602.
86. Li C, Sun J, Xiang Q, Liang Y, Zhao N, et al. Prognostic role of microRNA-21 expression in gliomas: a meta-analysis. J Neurooncol
2016;130:11-7.
87. Beyer S, Fleming J, Meng W, Singh R, Haque SJ, et al. The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their
Therapeutic Implications in Gliomas. Cancers (Basel) 2017;9:E85.
88. Wang Y, Wang X, Zhang J, Sun G, Luo H, et al. MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas. J Neurooncol
2012;106:217-24.
89. Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, et al. A restricted signature of serum miRNAs distinguishes glioblastoma
from lower grade gliomas. J Exp Clin Cancer Res 2016;35:124.
90. Areeb Z, Stylli SS, Koldej R, Ritchie DS, Siegal T, et al. MicroRNA as potential biomarkers in Glioblastoma. J Neurooncol 2015;125:237-
48.
91. Ouyang Q, Xu L, Cui H, Xu M, Yi L. MicroRNAs and cell cycle of malignant glioma. Int J Neurosci 2016;126:1-9.
92. Yan Z, Che S, Wang J, Jiao Y, Wang C, et al. miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway.
Tumour Biol 2015;36:5323-31.
93. Yang L, Li C, Liang F, Fan Y, Zhang S. MiRNA-155 promotes proliferation by targeting caudal-type homeobox 1 (CDX1) in glioma
cells. Biomed Pharmacother 2017;95:1759-64.
94. Costa PM, Cardoso AL, Mano M, de Lima MC. MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted
therapies. CNS Neurol Disord Drug Targets 2015;14:222-38.
95. Chen L, Kang C. miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks. Oncotarget 2015;6:38628-42.
96. Wang H, Xu T, Jiang Y, Yan Y, Qin R, et al. MicroRNAs in human glioblastoma: from bench to beside. Front Biosci (Landmark Ed)
2015;20:105-18.
97. Piwecka M, Rolle K, Belter A, Barciszewska AM, Żywicki M, et al. Comprehensive analysis of microRNA expression profile in
malignant glioma tissues. Mol Oncol 2015; 9:1324-40.
98 Banelli B, Forlani A, Allemanni G, Morabito A, Pistillo MP, et al. MicroRNA in Glioblastoma: An Overview. Int J Genomics
2017;2017:7639084.
99. Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, et al. Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun 2005;334:1351-8.
100. Santangelo A, Imbrucè P, Gardenghi B, Belli L, Agushi R, et al. A microRNA signature from serum exosomes of patients with glioma
as complementary diagnostic biomarker. J Neurooncol 2018;136:51-62.
101. Zhao H, Shen J, Hodges TR, Song R, Fuller GN, et al. Serum microRNA profiling in patients with glioblastoma: a survival analysis. Mol
Cancer 2017;16:59.
102. Liu S, Yin F, Zhang J, Wicha MS, Chang AE, et al. Regulatory roles of miRNA in the human neural stem cell transformation to glioma
stem cells. J Cell Biochem 2014;115:1368-80.
103. D'Urso PI, D'Urso OF, Storelli C, Mallardo M, Gianfreda CD, et al. miR-155 is up- regulated in primary and secondary glioblastoma
and promotes tumour growth by inhibiting GABA receptors. Int J Oncol 2012; 41:228-34.
104. Ling N, Gu J, Lei Z, Li M, Zhao J, Zhang HT, Li X. microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in
glioma. Oncol Rep. 2013 Nov;30(5):2111-8.
105. Zhou J, Wang W, Gao Z, Peng X, Chen X, et al. MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1. PLoS
One 2013;8:e83055.
106. Meng W, Jiang L, Lu L, Hu H, Yu H, et al. Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing
apoptosis. Cell Biol Int 2012;36:653-9.
107. Sun J, Shi H, Lai N, Liao K, Zhang S, et al. Overexpression of microRNA-155 predicts poor prognosis in glioma patients. Med Oncol
2014;31:911.
108. Zhou Y, Wang X, Liu Z, Huang X, Li X, et al. Prognostic role of microRNA-155 expression in gliomas: A meta-analysis. Clin Neurol
Neurosurg 2019;176:103-9.
109. Milani R, Brognara E, Fabbri E, Manicardi A, Corradini R, et al. Targeting miR-155-5p and miR-221-3p by peptide nucleic acids induces
Caspase-3 activation and apoptosis in temozolomide-resistant T98G glioma cells. Int J Oncol 2019; in press.
110. Finotti A, Allegretti M, Gasparello J, Giacomini P, Spandidos DA, et al. Liquid biopsy and PCR-free ultrasensitive detection systems in